Antenatal allopurinol for reduction of birth asphyxia induced brain damage (ALLO-Trial); a randomized double blind placebo controlled multicenter study

• Main Authors: von Lindern Jeannette (Author), van Meir Claudia A (Author), Bakker Saskia CMJER (Author), Huisjes Anjoke JM (Author), van Elburg Ruurd M (Author), Wouters Maurice GAJ (Author), Gavilanes AW Danilo (Author), Willekes Christine (Author), Oetomo Sidarto (Author), Porath Martina M (Author), Bos Arie F (Author), van Pampus Maria G (Author), Rijken Monique (Author), Bloemenkamp Kitty WM (Author), de Haan Timo R (Author), Oudijk Martijn A (Author), Torrance Helen L (Author), Rademaker Carin MA (Author), Benders Manon JNL (Author), Kaandorp Joepe J (Author), Boon Janine (Author), de Boer Inge P (Author), Rijnders Robbert JP (Author), Jacobs Corrie JWFM (Author), Uiterwaal Cuno SPM (Author), Mol Ben Willem J (Author), Visser Gerard HA (Author), van Bel Frank (Author), Derks Jan B (Author)
• Format: Book
• Published: BMC, 2010-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

<p>Abstract</p> <p>Background</p> <p>Hypoxic-ischaemic encephalopathy is associated with development of cerebral palsy and cognitive disability later in life and is therefore one of the fundamental problems in perinatal medicine. The xanthine-oxidase inhibitor allopurin...